[1]Okudaira M, Ohbu M, Okuda K.Idiopathic portal hypertension and its pathology[J].Semin Liver Dis, 2002, 22 (1) :59-72.
|
[2]Okuda K, Nakashima T, Okudaira M, et al.Anatomical basis of hepatic venographic alterations in idiopathic portal hypertension.[J].Liver, 1981, 1 (4) :255-263.
|
[3]Nakanuma Y, Tsuneyama K, Ohbu M, et al.Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver.[J].Pathol Res Pract, 2001, 197 (2) :65-76.
|
[4]兰孟东, 王笑梅, 石晓燕, 等.特发性门脉高压症的临床病理学特点[J].胃病学和肝病学杂志, 2008, 17 (1) :65-68.
|
[1] | Wenqian YU, Linjun XIE, Shiyi LI, Yanmei LOU, Guoheng JIANG, Hongyu LI, Zitong YAN, Xuan BAI, Jing LUO, Chi ZHANG, Guangcan LI, Xuefeng SHAN, Xin WANG. Association between hypertension and the risk of gallstone disease[J]. Journal of Clinical Hepatology, 2024, 40(6): 1215-1225. doi: 10.12449/JCH240623 |
[2] | Hong ZOU, Qiao ZHU, Yi WEN, Hongyin LIANG, Mingmei ZHOU, Kehui SHI, Jun WU, Lijun TANG. Current research status of left-sided portal hypertension after superior mesenteric-portal vein confluence pancreaticoduodenectomy[J]. Journal of Clinical Hepatology, 2023, 39(6): 1482-1487. doi: 10.3969/j.issn.1001-5256.2023.06.035 |
[3] | Chuntao XIAO, Xianqiu LI, Peiling GAN, Xiao PAN, Xian ZHOU. Influence of portal vein thrombosis on the prognosis of patients with liver cirrhosis based on propensity score matching[J]. Journal of Clinical Hepatology, 2021, 37(8): 1829-1835. doi: 10.3969/j.issn.1001-5256.2021.08.017 |
[4] | Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis(2020,Shanghai)[J]. Journal of Clinical Hepatology, 2020, 36(12): 2667-2674. doi: 10.3969/j.issn.1001-5256.2020.12.007 |
[5] | WANG Xin, HU YiYang, LIU Ping, FENG Qin. Association between hypertension and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2584-2588. doi: 10.3969/j.issn.1001-5256.2020.11.042 |
[6] | Yan Xin, Song XinYue, Dong HongJing, Yan Qi, Zhao YouYou, Jin JingLan. Acute extensive portal vein thrombosis with pulmonary embolism: a case report[J]. Journal of Clinical Hepatology, 2018, 34(4): 845-847. doi: 10.3969/j.issn.1001-5256.2018.04.031 |
[7] | Yang YuanYuan, Wang XiaoYan. Mechanisms of the development and progression of portal vein thrombosis[J]. Journal of Clinical Hepatology, 2018, 34(10): 2063-2068. doi: 10.3969/j.issn.1001-5256.2018.10.005 |
[8] | Zhang Ying, Liu QingYan, Li ZhiWei. Surgical diagnosis and treatment of portal vein thrombosis[J]. Journal of Clinical Hepatology, 2018, 34(10): 2058-2062. doi: 10.3969/j.issn.1001-5256.2018.10.004 |
[9] | Ma JingQin, Luo JianJun. Interventional treatment of portal vein thrombosis[J]. Journal of Clinical Hepatology, 2018, 34(10): 2053-2057. doi: 10.3969/j.issn.1001-5256.2018.10.003 |
[10] | Zhang Yu, Liu FuQuan. Treatment of portal vein thrombosis: Selection of anticoagulants[J]. Journal of Clinical Hepatology, 2018, 34(10): 2047-2052. doi: 10.3969/j.issn.1001-5256.2018.10.002 |
[11] | Zhou RenHua, Li Peng, Zhang YanTing, Yang Hua, Yang ShaoQi. Clinical manifestations of portal vein thrombosis and related risk factors in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(2): 275-278. doi: 10.3969/j.issn.1001-5256.2016.02.015 |
[12] | Zhang WenWen, Qi XingShun, Guo XiaoZhong. Significance of factor Ⅱ G20210A mutation in Budd-Chiari syndrome and portal vein thrombosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 310-314. doi: 10.3969/j.issn.1001-5256.2015.02.043 |
[13] | Cheng XiaoFei, Liang XiongBo, Xiong XiaoQing, Tang YongLi, Chen Ping. Relationship between hemodynamic changes of portal vein and hepatic artery measured by color Doppler ultrasound and FibroScan value in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(11): 1179-1181. doi: 10.3969/j.issn.1001-5256.2014.11.022 |
[14] | Yu LingXiang, Tan JunYuan, Xu ZhiWei, Jin XueYuan. Study on prevalence of hypertension in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(11): 1182-1185. doi: 10.3969/j.issn.1001-5256.2014.11.023 |
[15] | Wang Fang, Zhang Jing, Feng ShuXian, Song HouTan. Umbilical cord blood stem cell transplantation via the portal vein: analysis of the curative rate in 30 patients with decompensated liver cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(11): 824-827. |
[16] | Yang Li, Han GuoHong, . Revising consensus in portal hypertension: report of the Baveno V consensus workshop[J]. Journal of Clinical Hepatology, 2011, 27(2): 116-118. |
[17] | Li JingYu, Xu LiYang, Zhang Qiang, Liu Ming. Interventional diagnosis and therapy of portal hypertension resulting from hepatic vascular abnormalities[J]. Journal of Clinical Hepatology, 2011, 27(6): 643-646. |
[18] | Guo YinYan. The clinical value of D-dimer in cirrhotic patients with portal venous thrombosis[J]. Journal of Clinical Hepatology, 2010, 26(3): 304-305. |
[19] | Sun WenJing, Chen DongFeng. Probe into the pathogenesis and control methods of thrombopoiesis in portal system associated with pancreatitis[J]. Journal of Clinical Hepatology, 2010, 26(5): 484-486+492. |
[20] | Zhang FenMing, Gao SuQin, Kong DeZhi. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients[J]. Journal of Clinical Hepatology, 2007, 23(4): 277-279. |